Crohn's Disease

Rinvoq, an oral selective Janus kinase 1 inhibitor, helped induce endoscopic remission in patients with moderate-to-severe Crohn’s disease, according to study results.

AUSTIN, Texas — A quality improvement program that helps facilities make changes in practice structure and share best practices helped improve outcomes among patients with inflammatory bowel disease, according to research presented at Crohn’s and Colitis Congress.

AUSTIN, Texas — Real-world dose escalation of Stelara was safe and effective in patients with perianal Crohn’s disease, according to data presented at Crohn’s and Colitis Congress.

Healio Gastroenterology and Liver Disease presents some of the top stories and research from Crohn’s and Colitis Congress 2020.

AUSTIN, Texas — Though clinical data for nutrition as therapy in IBD is limited, physicians should not be deterred from discussing it with patients if patients participate in the decision and comply as if the diet is a drug, according to an expert at the Crohn’s and Colitis Congress.

AUSTIN, Texas — Approximately 30% of patients with inflammatory bowel disease developed new or worsening extraintestinal manifestations after receiving Entyvio, according to data presented at Crohn’s & Colitis Congress extraintestinal manifestations.

AUSTIN, Texas — The higher frequency of statural growth impairment in male children with Crohn’s disease appears to be due to less standardized height gain with skeletal maturation, rather than advanced bone age progression, according to preliminary data from the Growth Study presented at Crohn’s & Colitis Congress.

AUSTIN, Texas — Inflammatory bowel disease can vary drastically from patient to patient. There is not a one-size-fits-all therapy that can handle all that variance. At the Crohn’s and Colitis Congress, experts provided an overview of the numerous IBD therapies to provide the attending physicians with some baseline knowledge before they started with the scientific sessions.

AUSTIN, Texas — While a small risk for lymphoma exists in children with inflammatory bowel disease, occurrences are relatively rare, according to data presented at the Crohn’s and Colitis Congress.

AUSTIN, Texas – Knowing the burden of inflammatory bowel disease and the constraints of time with gastroenterologists, advanced practice providers and registered nurses need to step into the role of confidant and referral for patients suffering from the mental burden of IBD, according to a experts and patients at the Crohn’s and Colitis Congress.